Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Glutamate decarboxylase family member 3 pseudogene (GAD3P)** is a non-coding pseudogene in the human genome, homologous to the ancient vertebrate gene *GAD3*. The non-pseudogenized ortholog, GAD3, is a third member of the glutamate decarboxylase gene family in many vertebrates, sharing ancestry with GAD1 and GAD2 (which encode enzymes responsible for synthesizing the neurotransmitter GABA from glutamate)[2]. However, *GAD3* was lost in the hominid lineage (including humans, chimpanzees, and gorillas), such that in Homo sapiens only a nonfunctional pseudogene (GAD3P) remains[2].\n\nGAD1 and GAD2 encode the well-characterized enzymes GAD67 and GAD65. If GAD3 is expressed in other vertebrates, it may have distinct tissue specificity, subcellular localization, or regulatory properties compared to its paralogs[2]. However, there is no evidence that the human pseudogene GAD3P encodes a protein, nor is it associated with diseases or considered a therapeutic target.\n\nIf your goal is to annotate **functional targets**, GAD3P should be excluded, as it is not expressed as a protein nor targeted by drugs in humans. If you meant to refer to the active glutamate decarboxylase enzymes in humans, the correct targets are GAD1 and GAD2[2][4].\n\n**Note:** \n- There are also enzymatically active glutamate decarboxylases known as GAD65 (*GAD2*, cytoplasmic/vesicular pool) and GAD67 (*GAD1*, cytoplasmic form), both established as key for GABA synthesis[4].\n- The information that GAD3 is “lost in the hominid lineage” is well supported and recent[2]. No evidence supports a functional protein or therapeutic relevance in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate decarboxylase family member 3 pseudogene (GAD3P).